in Bodybuilding Science

Volume for muscle hypertrophy: the #1 trend in research in 2017

The year is almost over. Looking back at the science, I’d say 2017 was the year of volume for muscle hypertrophy. Volume is a key driver of hypertrophy, and the bulk of the evidence is starting to suggest it may be the most important variable.

The authors of a review paper went so far as to call volume “The Most Effective Variable in Resistance Training” in the title!

More and more researchers agree, too. I even heard Dr. Brad Schoenfeld mention it last week in an interview. In case you live under a rock, Schoenfeld is arguably the leading muscle hypertrophy researcher.

So, volume for muscle hypertrophy is key. That’s gotta be the #1 trend in hypertrophy research in 2017.

On the nutrition side, protein is still a popular topic, and protein powder is still the #1-selling sports supplement. In that spirit, I’m happy I got you 5% off from today’s sponsor, Genetidyne — a US-based company. Just enter DRMUSCLE5 as a coupon when you check out.

Here’s why I like Genetidyne:

– They sell only supplements that have been proven to work, without hype or fluff

– They use only efficacious dosages based on clinical studies (Bill Haskins, the founder, has a Master’s Degree in Exercise Physiology)

– They say they’re founded on morals and ethics, and based on my communications with Bill, I trust them

To be honest, that’s a rare sight in the supplement industry, where most promotions are misleading, to say the least. Fake before-and-after photos anyone?

Personally, I’d recommend the Unflavored Whey Protein Isolate Powder. I’ve used a powder like that for years. No artificial flavour, no sugar, no sugar substitute. Just the good stuff. You get 27 g of protein per 30 g serving — that’s the most I’ve ever seen. In other words, the protein is very pure.

Genetidyne only ships in the US. Enter coupon code DRMUSCLE5 at checkout to save 5%:

https://genetidyne.com/

Thanks for sticking around this year. I appreciate it. Best wishes for huge gains in 2018,

Carl Juneau, PhD

Write a Comment

Comment